Skip to main content
SpringerLink
Log in

Drug Development, Regulatory Assessment, and Postmarketing Surveillance

  • Book
  • © 1981

Overview

Editors:
  1. William M. Wardell

    1. The University of Rochester School of Medicine and Dentistry, Rochester, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Giampaolo Velo

    1. University of Padua, Verona, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: NATO Science Series A: (NSSA, volume 39)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (36 chapters)

  1. Front Matter

    Pages i-x
    Download chapter PDF

  2. Introduction: Science and Government in Drug Development, Regulatory Assessment, and Postmarketing Surveillance

    1. Introduction: Science and Government in Drug Development, Regulatory Assessment, and Postmarketing Surveillance

      • William M. Wardell
      Pages 1-13

  3. Drug Assessment and Regulation

    1. Front Matter

      Pages 15-15
      Download chapter PDF

    2. Preclinical Requirements, Guidelines, and Regulations: Public Safety and Impact on Drug Development

      1. Preclinical Testing of New Drugs the CPMP Guidelines as a Model for International Harmonisation
        • J. P. Griffin
        Pages 19-36
      2. Preclinical Guidelines for the Testing of New Drugs: Pharmacodynamic Aspects
        • F. Gross
        Pages 37-42
      3. Preclinical Guidelines: A Reply
        • George Zajicek
        Pages 43-57

    3. Clinical Requirements, Guidelines, and Regulations: Current Status and Future Prospects

      1. The Development of Clinical Guidelines
        • M. N. G. Dukes
        Pages 61-63
      2. Clinical Guidelines for the Assessment and Evaluation of Drugs
        • F. Gross
        Pages 64-70
      3. Clinical Guidelines Session
        • William M. Wardell, Giampaolo Velo
        Pages 71-75

    4. The Problem of Special Populations in Providing Evidence of Safety and Efficacy for Drug Registration

      1. The Problem of Special Populations and Issues of Safety and Efficacy for Drug Registration
        • D. R. Laurence
        Pages 79-84
      2. Special Populations and Evidence of Safety and Efficacy for Drug Registration
        • Marc Bogaert
        Pages 85-89
      3. Special Populations: Summary of the Discussion
        • William M. Wardell, Giampaolo Velo
        Pages 90-93

    5. The Repeated Examination of Data: Is it Scientific? Is it Ethical?

      1. Sensitivity of Therapeutic Trials: Sequential Analysis: Peeking at Interim Results: Is it Scientific? Is it Ethical?
        • D. R. Laurence
        Pages 97-109
      2. Some Problems of Multiplicity in Long-Term Intervention Studies
        • Michael Gent
        Pages 110-117
      3. Sequential Analysis: Reply to the Presentations
        • William M. Wardell, Giampaolo Velo
        Pages 119-119

    6. Taking Account of Characteristics of Therapy in the Analysis of Clinical Trials

      1. Strategies for Improving the Efficiency of Long-Term Intervention Studies
        • Michael Gent
        Pages 123-133
      2. Characteristics of Therapy in Statistical Analysis
        • Max Hamilton
        Pages 134-138

    7. The Scientific and Ethical Basis of the Evaluation of Medicines: Are Randomized Controlled Studies Inherently Unethical and Illegal?

      1. Report: The Scientific and Ethical Basis of the Clinical Evaluation of Medicines
        • William M. Wardell, Giampaolo Velo
        Pages 141-152
      2. General Introduction to the Ditchley Report
        • D. R. Laurence
        Pages 153-154

    8. What has been Achieved by Drug Regulations and Drug Regulators?

      1. The Effects of Drug Regulation: A Systematic Analysis
        • M. N. G. Dukes, Inga Lunde
        Pages 157-161
Back to top

Keywords

About this book

This volume is the outcome of the International School of Phar­ macology course sponsored as a NATO Advanced Study Institute and held in Erice (Sicily) at the Ettore Majorana Centre for Scientific Culture from October 3 through 12, 1980. The course, which consisted of lectures and teaching seminars, examined issues of international importance in all phases of drug development, assessment, and regu­ lation. In order to recreate both the atmosphere and substance of the meeting, a variety of materials are included here: the papers pre­ sented by the lecturers, a selection of key items from the supple­ mentary materials provided by the lecturers to the participants, notes on issues raised during the discussions, and accounts of certain special sessions arranged in response to interests expressed by those attending. The course covered two broad areas represented here by parts of the book. Part I, "Drug Assessment and Regulation," is based on the nine sessions of the course that ranged in focus from recent developments in the science of clinical pharmacology and drug development to discussions of whether and how the regulation of drug development can (or should) be harmonized internationally. In Part 11, "Postmarketing Surveillance," many aspects of this important subject are presented. Arguments outlining the potential benefits of national and international postmarketing surveillance systems are qualified by consideration of the problems inherent in devising and using these systems.

Editors and Affiliations

  • The University of Rochester School of Medicine and Dentistry, Rochester, USA

    William M. Wardell

  • University of Padua, Verona, Italy

    Giampaolo Velo

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation